Oman Pharmaceuticals & Healthcare Q1 2021

Oman Pharmaceuticals & Healthcare Q1 2021

Key View:

Oman's economy will contract in 2020 amid the effects of the sharp drop in oil prices and the Covid-19 pandemic. Thiswill mean further price revisions and continued tight scrutiny of the pharmaceutical industry to ensure the government's healthspending yields the best value for money possible, while still providing a good service across the country. A high burden of chronicdiseases and alignment of regulations with the rest of the Gulf Cooperation Council countries will provide a little alleviation from thedrawback of Oman's small market size while the country is also moving ahead with a number of agreements with internationalpartners to help develop its health sector. Meanwhile, the planned investment of OMR497mn into a new Medical City in Muscat, aspart of the government's economic expansion plan, should help encourage an increase in private sector investment into the sector.

Key View
Oman Pharmaceutical & Healthcare Covid-19 Impact
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Middle East And North Africa Pharmaceuticals Market Presents A Diverse Mix Of Opportunities
Oman Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
National Pharmaceutical Industries
Zynova/Oman Pharmaceutical Products Company
Oman Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook